Suntrust Banks’s Harvard Bioscience HBIO Stock Holding History

Suntrust Banks’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-5,985	Closed	-$171K	–	1560
2016 Q2	$171K	Hold	5,985	–	–	﹤0.01%	1411
2016 Q1	$180K	Hold	5,985	–	–	﹤0.01%	1367
2015 Q4	$207K	Hold	5,985	–	–	﹤0.01%	1309
2015 Q3	$226K	Hold	5,985	–	–	﹤0.01%	1116
2015 Q2	$341K	Buy	+5,985	New	+$341K	﹤0.01%	968

Other funds holding HBIO

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Suntrust Banks's HBIO Position: Q3 2016 in Review

Suntrust Banks sold out of Harvard Bioscience (HBIO) in Q3 2016, closing a stake of 5,985 shares — an estimated $171K sold.

Suntrust Banks first reported a position in HBIO in Q2 2015 and held it in 5 quarters. The position peaked at $341K in Q2 2015. 69 funds tracked by Wall St. Rank hold HBIO as of Q3 2016.

Suntrust Banks reported no remaining Harvard Bioscience position as of Q3 2016 after selling out during the quarter.
Suntrust Banks sold 5,985 Harvard Bioscience shares in Q3 2016, an estimated $171K.
Suntrust Banks first reported a position in Harvard Bioscience in Q2 2015 and held it in 5 quarters.
Suntrust Banks's Harvard Bioscience position peaked at $341K in Q2 2015.
69 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2016.

Based on Suntrust Banks's 13F filing for Q3 2016, filed 9 Nov 2016.